Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12552850 | GLP-1/GIP dual agonist, long-acting conjugate thereof, and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-10-18 | 0 | 31 |
| 12551527 | Drug delivery systems for treatment of infections | 🖼🧊📄§ | 2026-02-17 | 2038-12-28 | 0 | 31 |
| 12551525 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | 🖼🧊📄§ | 2026-02-17 | 2045-03-20 | 0 | 31 |
| 12551498 | Treatment of P53-deficient cancers | 🖼🧊📄§ | 2026-02-17 | 2040-07-27 | 0 | 31 |
| 12552873 | Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2040-06-02 | 0 | 31 |
| 12553047 | Engineered immunostimulatory bacterial strains and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-09-23 | 0 | 31 |
| 12551456 | Methods to improve health and wellbeing in ruminants | 🖼🧊📄§ | 2026-02-17 | 2041-01-14 | 0 | 31 |
| 12551478 | Quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity | 🖼🧊📄§ | 2026-02-17 | 2039-09-25 | 0 | 31 |
| 12552765 | Small molecule modulators of pantothenate kinases | 🖼🧊📄§ | 2026-02-17 | 2040-12-14 | 0 | 31 |
| 12551494 | Pharmaceutical composition for preventing or treating dengue fever | 🖼🧊📄§ | 2026-02-17 | 2042-02-17 | 0 | 31 |
| 12552855 | CD33 targeted immunotherapies | 🖼🧊📄§ | 2026-02-17 | 2040-05-07 | 0 | 31 |
| 12552787 | Quinazoline compound | 🖼🧊📄§ | 2026-02-17 | 2041-07-23 | 0 | 31 |
| 12551504 | Mitochondrial augmentation therapy of pancreatic diseases | 🖼🧊📄§ | 2026-02-17 | 2039-07-22 | 0 | 31 |
| 12551465 | Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition | 🖼🧊📄§ | 2026-02-17 | 2041-04-22 | 0 | 31 |
| 12551468 | Pharmaceutical composition for oral administration, for treatment of liver cancer | 🖼🧊📄§ | 2026-02-17 | 2040-11-25 | 0 | 31 |
| 12552840 | Identification of inhibitor peptides to bind with n-terminal spike (s) and nonstructural protein (NSP) sequences of SARS-COV2 b.1.617.2 Delta or Omicron variants alone and combination with drug(s) for targeted antiviral therapy | 🖼🧊📄§ | 2026-02-17 | 2042-05-04 | 0 | 31 |
| 12552773 | Compound for specifically enhancing spatial coupling degree of TRPV4-KCa2.3 complex and use thereof | 🖼🧊📄§ | 2026-02-17 | 2042-01-27 | 0 | 31 |
| 12551506 | Differentiation of olfactory mucosa derived mesenchymal stem cells to schwann cells for peripheral nerve repair | 🖼🧊📄§ | 2026-02-17 | 2042-04-25 | 0 | 31 |
| 12551474 | Use of pridopidine for the treatment of fragile X syndrome | 🖼🧊📄§ | 2026-02-17 | 2042-01-31 | 0 | 31 |
| 12551475 | Methods and compositions for treating RNA viral infections | 🖼🧊📄§ | 2026-02-17 | 2041-06-01 | 0 | 31 |
| 12552799 | Triazolone compounds | 🖼🧊📄§ | 2026-02-17 | 2041-03-25 | 0 | 31 |
| 12551487 | PI3K inhibitor for use in the therapy of b cell lymphoma | 🖼🧊📄§ | 2026-02-17 | 2040-07-01 | 0 | 31 |
| 12551495 | Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection | 🖼🧊📄§ | 2026-02-17 | 2041-03-24 | 0 | 31 |
| 12552779 | 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases | 🖼🧊📄§ | 2026-02-17 | 2041-07-09 | 0 | 31 |
| 12551543 | Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof | 🖼🧊📄§ | 2026-02-17 | 2042-03-10 | 0 | 31 |
| 12552838 | Adeno-associated virus with engineered capsid | 🖼🧊📄§ | 2026-02-17 | 2041-04-19 | 0 | 31 |
| 12551467 | Compositions and methods of modulating S-nitrosylation | 🖼🧊📄§ | 2026-02-17 | 2042-08-30 | 0 | 31 |
| 12551513 | Bacillus coagulans having blood glucose reduction efficacy, and application thereof | 🖼🧊📄§ | 2026-02-17 | 2041-06-21 | 0 | 31 |
| 12551548 | HIV vaccine compositions, methods, and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-06-10 | 0 | 31 |
| 12551545 | African swine fever virus chimeric protein, vaccine composition, preparation method and use thereof | 🖼🧊📄§ | 2026-02-17 | 2041-03-09 | 0 | 31 |
| 12552826 | PRMT5 inhibitors | 🖼🧊📄§ | 2026-02-17 | 2039-08-05 | 0 | 31 |
| 12551733 | Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-02-05 | 0 | 31 |
| 12552841 | CRA4S1 gene, encoded CRA4S1 protein, and application | 🖼🧊📄§ | 2026-02-17 | 2039-12-11 | 0 | 31 |
| 12551569 | RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use | 🖼🧊📄§ | 2026-02-17 | 2045-03-30 | 0 | 31 |
| 12551553 | Methods for manufacturing an adjuvant | 🖼🧊📄§ | 2026-02-17 | 2039-11-27 | 0 | 31 |
| 12551449 | Tunable degradation in hydrogel microparticles | 🖼🧊📄§ | 2026-02-17 | 2040-06-05 | 0 | 31 |
| 12552775 | Compounds and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-11-22 | 0 | 31 |
| 12551493 | Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same | 🖼🧊📄§ | 2026-02-17 | 2040-10-21 | 0 | 31 |
| 12552834 | Selective MENA binding peptides | 🖼🧊📄§ | 2026-02-17 | 2042-01-25 | 0 | 31 |
| 12551532 | Long-acting amylin receptor agonists and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2044-09-12 | 0 | 31 |
| 12552793 | Purine derivative and medical use thereof | 🖼🧊📄§ | 2026-02-17 | 2040-12-30 | 0 | 31 |
| 12551523 | HIF-1 activator | 🖼🧊📄§ | 2026-02-17 | 2042-10-04 | 0 | 31 |
| 12552795 | Pyrrolotriazine derivatives for treating kit-and PDGFRA-mediated diseases | 🖼🧊📄§ | 2026-02-17 | 2040-04-08 | 0 | 31 |
| 12551536 | Semaglutide in medical therapy | 🖼🧊📄§ | 2026-02-17 | 2045-04-09 | 0 | 31 |
| 12551502 | Testosterone enhancing compositions and methods | 🖼🧊📄§ | 2026-02-17 | 2045-03-28 | 0 | 31 |
| 12551477 | Oral antagonist compositions for nicotine burning relief | 🖼🧊📄§ | 2026-02-17 | 2040-09-22 | 0 | 31 |
| 12552754 | Leflutrozole compositions of matter and processes for preparation | 🖼🧊📄§ | 2026-02-17 | 2045-07-23 | 0 | 31 |
| 12551481 | Molecular targets for addiction | 🖼🧊📄§ | 2026-02-17 | 2040-12-18 | 0 | 31 |
| 12552824 | C-mannoside compounds useful for the treatment of urinary tract infections | 🖼🧊📄§ | 2026-02-17 | 2043-04-28 | 0 | 31 |
| 12551522 | Herbal compositions and methods for treating and preventing SARS-CoV-2 virus infection | 🖼🧊📄§ | 2026-02-17 | 2042-11-09 | 0 | 31 |